Rho-kinase signalling mediates endotoxin hypersensitivity after partial hepatectomy

British Journal of Surgery

Volumn 95, Issue 8, 2008, Pages 976-984

  Slotta, J E ^a,b   Laschke, M W ^a,b   Menger, M D ^b   Thorlacius, H ^a,c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b SAARLAND UNIVERSITY   (Germany)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALANINE AMINOTRANSFERASE; CHEMOKINE; ENDOTOXIN; FASUDIL; RHO KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HYPERSENSITIVITY; INFECTION SENSITIVITY; LIVER DYSFUNCTION; LIVER INJURY; LIVER RESECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ALANINE TRANSAMINASE; AMIDES; ANALYSIS OF VARIANCE; ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HEPATECTOMY; HEPATITIS; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; PROTEIN KINASE INHIBITORS; PYRIDINES; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 48249153495     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6082     Document Type: Article

References (47)

1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318.
2. Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54: 289-296.
3. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 2006; 26: 1175-1186.
4. Arii S, Shibagaki M, Takahashi S, Taki Y, Yokoo N, Jikko A et al. Changes in the reticuloendothelial phagocytic function after partial hepatectomy. J Lab Clin Med 1985; 105: 668-672.
5. Boermeester MA, Houdijk AP, Meyer S, Cuesta MA, Appelmelk BJ, Wesdorp RI et al. Liver failure induces a systemic inflammatory response. Prevention by recombinant N-terminal bactericidal/permeability-increasing protein. Am J Pathol 1995; 147: 1428-1440.
6. Schindl MJ, Millar AM, Redhead DN, Fearon KC, Ross JA, Dejong CH et al. The adaptive response of the reticuloendothelial system to major liver resection in humans. Ann Surg 2006; 243: 507-514.
7. Wang X, Andersson R, Soltesz V, Bengmark S. Bacterial translocation after major hepatectomy in patients and rats. Arch Surg 1992; 127: 1101-1106.
8. Cornell RP. Acute phase responses after acute liver injury by partial hepatectomy in rats as indicators of cytokine release. Hepatology 1990; 11: 923-931.
9. Kono H, Fujii H, Matsuda M, Yamamoto M, Matsumoto Y. Gadolinium chloride prevents mortality in hepatectomized rats given endotoxin. J Surg Res 2001; 96: 204-210.
10. Suzuki S, Nakamura S, Serizawa A, Sakaguchi T, Konno H, Muro H et al. Role of Kupffer cells and the spleen in modulation of endotoxin-induced liver injury after partial hepatectomy. Hepatology 1996; 24: 219-225.
11. Thorlacius K, Slotta JE, Laschke MW, Wang Y, Menger MD, Jeppsson B et al. Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury. J Leukoc Biol 2006; 79: 923-931.
12. Noren NK, Liu BP, Burridge K, Kreft B. p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J Cell Biol 2000; 150: 567-580.
13. Kawaguchi A, Ohmori M, Harada K, Tsuruoka S, Sugimoto K, Fujimura A. The effect of a Rho kinase inhibitor Y-27632 on superoxide production, aggregation and adhesion in human polymorphonuclear leukocytes. Eur J Pharmacol 2000; 403: 203-208.
14. Hickson GR, Echard A, O'Farrell PH. Rho-kinase controls cell shape changes during cytokinesis. Curr Biol 2006; 16: 359-370.
15. Hirai F, Nakayamada S, Okada Y, Saito K, Kurose H, Mogami A et al. Small GTPase Rho signaling is involved in betal integrin-mediated up-regulation of intercellular adhesion molecule 1 and receptor activator of nuclear factor kappaB ligand on osteoblasts and osteoclast maturation. Biochem Biophys Res Commun 2007; 356: 279-285.
16. Ikeda F, Terajima H, Shimahara Y, Kondo T, Yamaoka Y. Reduction of hepatic ischemia/reperfusion-induced injury by a specific ROCK/Rho kinase inhibitor Y-27632. J Surg Res 2003; 109: 155-160.
17. Murata T, Arii S, Mori A, Imamura M. Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis. J Surg Res 2003; 114: 64-71.
18. Greene AK, Puder M. Partial hepatectomy in the mouse: technique and perioperative management. J Invest Surg 2003; 16: 99-102.
19. Hacker G. The morphology of apoptosis. Cell Tissue Res 2000; 301: 5-17.
20. Moloney WC, McPherson K, Fliegelman L. Esterase activity in leukocytes demonstrated by the use of naphthol AS-D chloroacetate substrate. J Histochem Cytochem 1960; 8: 200-207.
21. Mochida S, Ogata I, Hirata K, Ohta Y, Yamada S, Fujiwara K. Provocation of massive hepatic necrosis by endotoxin after partial hepatectomy in rats. Gastroenterology 1990; 99: 771-777.
22. Takayashiki T, Yoshidome H, Kimura F, Ohtsuka M, Shimizu Y, Kato A et al. Increased expression of toll-like receptor 4 enhances endotoxin-induced hepatic failure in partially hepatectomized mice. J Hepatol 2004; 41: 621-628.
23. Mahidhara R, Billiar TR. Apoptosis in sepsis. Crit Care Med 2000; 28(Suppl): N105-N113.
24. Orlando KA, Stone NL, Pittman RN. Rho kinase regulates fragmentation and phagocytosis of apoptotic cells. Exp Cell Res 2006; 312: 5-15.
25. Lai JM, Hsieh CL, Chang ZF. Caspase activation during phorbol ester-induced apoptosis requires ROCK-dependent myosin-mediated contraction. J Cell Sci 2003; 116: 3491-3501.
26. Bour ES, Ward LK, Cornman GA, Isom HC. Tumor necrosis factor-alpha-induced apoptosis in hepatocytes in long-term culture. Am J Pathol 1996; 148: 485-495.
27. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146: 1220-1234.
28. Kwon AH, Qiu Z. Neutrophil elastase inhibitor prevents endotoxin-induced liver injury following experimental partial hepatectomy. Br J Surg 2007; 94: 609-619.
29. Bergheim I, Luyendyk JP, Steele C, Russell GK, Guo L, Roth RA et al. Metformin prevents endotoxin-induced liver injury after partial hepatectomy. J Pharmacol Exp Ther 2006; 316: 1053-1061.
30. Nagata Y, Tanaka N, Orita K. Endotoxin-induced liver injury after extended hepatectomy and the role of Kupffer cells in the rat. Surg Today 1994; 24: 441-448.
31. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000; 351: 95-105.
32. Lecuona E, Ridge K, Pesce L, Batlle D, Sznajder JI. The GTP-binding protein RhoA mediates Na,K-ATPase exocytosis in alveolar epithelial cells. Mol Biol Cell 2003; 14: 3888-3897.
33. Fukata Y, Oshiro N, Kinoshita N, Kawano Y, Matsuoka Y, Bennett V et al. Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. J Cell Biol 1999; 145: 347-361.
34. Wiedemann A, Patel JC, Lim J, Tsun A, van Kooyk Y, Caron E. Two distinct cytoplasmic regions of the beta2 integrin chain regulate RhoA function during phagocytosis. J Cell Biol 2006; 172: 1069-1079.
35. Mallat Z, Gojova A, Sauzeau V, Brun V, Silvestre JS, Esposito B et al. Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice. Circ Res 2003; 93: 884-888.
36. Yin L, Morishige K, Takahashi T, Hashimoto K, Ogata S, Tsutsumi S et al. Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Mol Cancer Ther 2007; 6: 1517-1525.
37. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M et al. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 2000; 57: 976-983.
38. Nagumo H, Sasaki Y, Ono Y, Okamoto H, Seto M, Takuwa Y. Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am J Physiol Cell Physiol 2000; 278: C57-C65.
39. Shimokawa H, Seto M, Katsumata N, Amano M, Kozai T, Yamawaki T et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res 1999; 43: 1029-1039.
40. Genda T, Sakamoto M, Ichida T, Asakura H, Kojiro M, Narumiya S et al. Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology 1999; 30: 1027-1036.
41. Takamura M, Sakamoto M, Genda T, Ichida T, Asakura H, Hirohashi S. Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632. Hepatology 2001; 33: 577-581.
42. Hennenberg M, Biecker E, Trebicka J, Jochem K, Zhou Q, Schmidt M et al. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats. Gastroenterology 2006; 130: 838-554.
43. Zhou Q, Hennenberg M, Trebicka J, Jochem K, Leifeld L, Biecker E et al. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut 2006; 55: 1296-1305.
44. Kelly DM, Demetris AJ, Fung JJ, Marcos A, Zhu Y, Subbotin V et al. Porcine partial liver transplantation: a novel model of the 'small-for-size' liver graft. Liver Transpl 2004; 10: 253-263.
45. Vicari RM, Chaitman B, Keefe D, Smith WB, Chrysant SG, Tonkon MJ et al. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. Fasudil Study Group. J Am Coll Cardiol 2005; 46: 1803-1811.
46. Shimokawa H, Hiramori K, Iinuma H, Hosoda S, Kishida H, Osada H et al. Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovasc Pharmacol 2002; 40: 751-761.
47. Ishikura K, Yamada N, Ito M, Ota S, Nakamura M, Isaka N et al. Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension. Circ J 2006; 70: 174-178.